The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations

NCT03339778 · clinicaltrials.gov ↗
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

IMMUNOe Research Centers